P
Poolbeg Pharma PLC
LSE:POLB
Poolbeg Pharma PLC
LSE:POLB
Price:
4.125
GBX
-1.2%
Market Closed
Market Cap:
£28.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Poolbeg Pharma PLC
LSE:POLB
|
UK |
|
C
|
Carpenter Tan Holdings Ltd
HKEX:837
|
CN |
|
Hung Hing Printing Group Ltd
HKEX:450
|
HK |
|
ONEOK Inc
NYSE:OKE
|
US |
|
Hainan Yedao Group Co Ltd
SSE:600238
|
CN |
|
L
|
Larsen & Toubro Ltd
BSE:500510
|
IN |
|
P
|
Powdertech Co Ltd
TSE:5695
|
JP |
|
G
|
G Energy SA
WSE:GNG
|
PL |
|
G
|
Grand House Mulia Tbk PT
IDX:HOMI
|
ID |
|
Jyoti Ltd
BSE:504076
|
IN |
|
Brookfield Business Partners LP
NYSE:BBU
|
BM |
|
E
|
Encanto Potash Corp
XTSX:EPO.H
|
CA |
|
Miroku Corp
TSE:7983
|
JP |
|
CIFI Holdings (Group) Co Ltd
HKEX:884
|
CN |
|
RPMGlobal Holdings Ltd
ASX:RUL
|
AU |
|
Anji Technology Co Ltd
TWSE:6477
|
TW |
Balance Sheet
Balance Sheet Decomposition
Poolbeg Pharma PLC
Poolbeg Pharma PLC
Balance Sheet Decomposition is not available for
Poolbeg Pharma PLC
Poolbeg Pharma PLC
Balance Sheet
Poolbeg Pharma PLC
Poolbeg Pharma PLC
Currency: GBP
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
21
|
16
|
12
|
8
|
|
| Cash Equivalents |
21
|
16
|
12
|
8
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
|
| Total Current Assets |
21
|
17
|
13
|
9
|
|
| Intangible Assets |
2
|
2
|
2
|
2
|
|
| Total Assets |
23
N/A
|
19
-16%
|
15
-20%
|
10
-34%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+121%
|
1
+2%
|
1
-1%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
5
|
9
|
14
|
|
| Additional Paid In Capital |
23
|
23
|
23
|
23
|
|
| Total Equity |
23
N/A
|
18
-19%
|
14
-21%
|
9
-36%
|
|
| Total Liabilities & Equity |
23
N/A
|
19
-16%
|
15
-20%
|
10
-34%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
500
|
500
|
500
|
500
|
|
Switch to:
Switch to:
See Also
Discover More
